This is a common and benign pigmented lesion of the skin, composed of an increase in melanocytes at the dermal-epidermal junction. It is closely related to the melanocytic nevus and indeed, some junctional nevi share histologic features with lentigos, occasionally called jentigos.
Epidemiology Disease Associations Pathogenesis Laboratory/Radiologic/Other Diagnostic Testing Gross Appearance and Clinical Variants Histopathological Features and Variants Special Stains/Immunohistochemistry/Electron Microscopy Differential Diagnosis Prognosis and Treatment Commonly Used Terms
EPIDEMIOLOGY CHARACTERIZATION INCIDENCE Common AGE RANGE-MEDIAN All SEX (M:F) Both
DISEASE ASSOCIATIONS CHARACTERIZATION CARNEY COMPLEX
Carney complex: in a patient with multiple blue naevi and lentigines, suspect cardiac myxoma.
Bleasel NR, Stapleton KM.
Department of Dermatology, Royal Hobart Hospital, Tasmania, Australia.
Australas J Dermatol 1999 Aug;40(3):158-60 Abstract quote
Carney complex is characterized by spotty pigmentation (blue naevi and lentigines), myxomas (cardiac, cutaneous, mammary), endocrine over-activity (Cushing's syndrome, acromegaly), testicular tumours, and schwannomas.
We report a male with multiple blue naevi, lentigines, testicular large cell calcifying Sertoli-cell tumour and four cardiac myxomas. The myxomas caused two cerebrovascular accidents and a myocardial infarction. All patients with multiple blue naevi or lentigines should be investigated for the life-threatening association of cardiac myxomas.
Genital lentigines in a 6-year-old boy with a family history of Cowden's disease: clinical and genetic evidence of the linkage between Bannayan-Riley-Ruvacalba syndrome and Cowden's disease.
Blum RR, Rahimizadeh A, Kardon N, Lebwohl M, Wei H.
Department of Dermatology, Mount Sinai Medical Center, New York, New York, USA 10029, USA.
J Cutan Med Surg 2001 May-Jun;5(3):228-30 Abstract quote
BACKGROUND: In 1997, it was reported that a PTEN gene deletion, a common genetic mutation in Cowden's disease (CD), was identified in a patient with Bannayan-Riley-Ruvacalba (BRR), suggesting that the two diseases were allelic. However, the clinical overlap between the two diseases has largely remained unclear.
OBJECTIVE: To confirm the genetic and clinical association in a family segregating both CD and BRR.
METHODS: Clinical evaluation and genetic analysis using a denaturing gradient gel electrophoresis (DGGE), temporal temperature gradient electrophoresis (TTGE), and DNA sequencing techniques.
RESULTS: Our patient presents with typical BRR clinical manifestations, including multiple lentigines on his penis, while his mother presents with typical manifestations of CD, including multiple malignancies. Genetic analyses of leukocytes from the patient and his mother showed mutations in exon 8 that was identified as the presumably truncating mutation R335X.
CONCLUSION: This report provides clinical evidence that both BRR and CD are closely related and confirms the PTEN gene mutation in BRR and CD patients segregating in the same family, thus confirming the genetic linkage between the two genodermatoses.
Tong KL, Ding ZP, Chua T.
Department of Cardiology, National Heart Centre, Singapore.
Singapore Med J 2001 Jul;42(7):328-31 Abstract quote
The Leopard syndrome is a complex of multisystemic congenital abnormalities characterised by lentiginosis, electrocardiographic conduction abnormalities, ocular hypertelorism, pulmonary stenosis, abnormalities of genitalia, retardation of growth and deafness (sensorineural). Hypertrophic cardiomyopathy, though not included in the mnemonic, is often associated.
Although the Leopard syndrome is rare, it is important to recognise it since it can be associated with serious cardiac disease. It is advisable to follow up patients with Leopard syndrome for new onset of cardiac abnormalities and to monitor the progression of existing cardiac disease.
We present a case report and review of the literature of this syndrome.
Lentiginous macules and patches of neurofibromatosis (an approach to better terminology).
Amer M, Mostafa FF, Nasr AN.
Department of Dermatology and Pathology, University of Zagazig, Faculty of Medicine, Egypt.
J Eur Acad Dermatol Venereol 2001 Jan;15(1):39-42 Abstract quote
BACKGROUND AND OBJECTIVES: Freckles (ephelides) are small, light brown macules of sun-exposed areas in fair-skinned subjects. On the other hand, freckle-like pigmentation of the axilla is a highly characteristic feature of neurofibromatosis. To what extent (clinically and pathologically) are the two pigmentary defects similar? And to what extent are cafe-au-lait patches and freckle-like lesions similar pathologically?
SUBJECTS AND METHODS: Ten cases of neurofibromatosis and 10 cases of freckles were examined clinically. Two biopsies were taken from the former; one obtained from an axillary freckle-like lesion, and the other from a cafe-au-lait patch. One biopsy only was taken from freckles. The biopsies were processed for haematoxylin and eosin, silver stain and transmission electron microscopy.
RESULTS: Obvious differences were detected between freckles (ephelides) and freckle-like lesions in cases of neurofibromatosis. Cafe-au-lait patches and freckle-like lesions showed the same pathological changes of lentigo simplex, with increased melanin pigment from the basal layer up to the stratum corneum, moderate elongation of the rete ridges and mild inflammatory infiltrate intermingled with melanophages. Electron microscopy revealed an increase in melanocyte number and the presence of giant melanin granules in freckle-like pigmentation as well as cafe-au-lait patches. These ultrastructural freckles (ephelides) showed an increase in activity but not the number of melanocytes.
CONCLUSIONS: The term freckle-like should be changed to lentiginous macules of neurofibromatosis. On the other hand, the cafe-au-lait patches should be considered as lentiginous patches. Freckles should be restricted to sun-exposed areas in fair-skinned persons only.
PATHOGENESIS CHARACTERIZATION APOPTOSIS
Hamartoma and lentiginosis syndromes: clinical and molecular aspects.
Marsh DJ, Stratakis CA.
Cancer Genetics, Kolling Institute of Medical Research, Royal North Shore Hospital, and Sydney University, Sydney, Australia.
Front Horm Res 2001;28:167-213 Abstract quote
The classic hamartoma syndromes and the related conditions discussed in this chapter show varying degrees of phenotypic and genetic overlap. Knowledge of the susceptibility genes underlying their phenotypes has provided additional information for the classification of these syndromes.
Germline PTEN mutations appear to cause both CS and BRR. These two syndromes are therefore likely to be different manifestations of a single disease with variable expression. It has been suggested that PTEN mutation-positive CS and BRR should be grouped as a single entity for clinical purposes and classified as the 'PTEN hamartoma-tumour syndrome' . Germline PTEN mutations are unlikely to cause JPS. However, germline SMAD4 mutation, especially a well-described 4-bp deletion, can be used to confirm a clinical diagnosis of JPS. Like the hamartoma syndromes, the lentiginoses also show substantial clinical overlap; it remains to be seen whether this is reflected in the molecular pathways that are involved in the pathogenesis of these syndromes. Given that the degree and type of cancer susceptibility between the hamartoma and lentiginosis syndromes is different, clarification of these syndromes at the molecular level is predicted to allow directed cancer surveillance.
The molecular story is still evolving with regards to aspects of genetic heterogeneity, signalling pathways and the manner in which these hamartoma genes function in the development of their respective syndromes. It is likely that in all of these syndromes, tumours develop against a background created by loss of the growth-suppressive function of their susceptibility gene via mechanisms including disruption of the cell cycle and the activation of anti-apoptotic pathways.
CHARACTERIZATION RADIOLOGIC LABORATORY MARKERS EPILUMINESCENCE MICROSCOPY
Detection of a Novel Pigment Network Feature in Reticulated Black Solar Lentigo by High-Resolution Epiluminescence Microscopy
Norbert Haas, M.D.; Barbara Hermes, M.D.; Beate M. Henz, M.D.
Am J Dermatopathol 2002; 24(3):213-217 Abstract quote
Epiluminescence light microscopy (ELM) of pigmented skin lesions has led to a catalog of pigment network (PN) features. The objective of this study was to determine whether high-resolution ELM detects additional pigment structures not seen with conventional ELM.
Epiluminescence light microscopy was performed by placing the lens of a standard light microscope directly on the skin surface, with resulting enhanced optical resolution compared with ELM systems currently in general use. Eight reticulated black solar lentigines were studied. All lesions were viewed and analyzed using dermatoscopic criteria for the PN. In addition, they were all photographed, excised, and examined histologically. Two subtypes of black solar lentigines could be distinguished using generally accepted dermatoscopic criteria for the PN. Furthermore, a new pigment structure was detected, namely, pigment spots of equal color, shape, and size, which were regularly superimposed on and juxtaposed to the PN. Clinicopathologic correlation showed these spots to represent individual hyperpigmented corneocytes. Because such cells result from physiologic excessive pigment translocation via the epidermal melanocytic unit, we called them pigmented corneocytes. Pigmented corneocytes were seen in seven of eight black solar lentigines.
The ELM technique presented here allows for more detailed analysis and classification of the PN components. Pigmented corneocytes are proposed as an additional dermatoscopic criterion.
CHARACTERIZATION GENERAL VARIANTS OCULAR
Partial unilateral lentiginosis with ocular involvement.
Schaffer JV, Lazova R, Bolognia JL.
Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut 06520, USA.
J Am Acad Dermatol 2001 Feb;44(2 Suppl):387-90 Abstract quote
Partial unilateral lentiginosis (PUL) is an unusual pigmentary disorder characterized by numerous lentigines grouped within an area of normal skin; the pigmented macules are often in a segmental distribution with a sharp demarcation at the midline.
We report the first case of ocular involvement in a patient with this diagnosis. The patient, a 30-year-old Peruvian woman, had multiple brown macules on the left upper face in primarily a V1 and V2 distribution with a sharp demarcation at the midline of the forehead. The lesions first appeared near the hairline when she was 5 years of age, and then began to extend onto the face.
She also had a discrete area of brown pigmentation on the left lateral bulbar conjunctiva. Because the patient had been previously diagnosed by several dermatologists as having either a speckled lentiginous nevus or a nevus of Ota, we draw attention to the entity PUL and the possibility of ocular involvement.
Extensive partial unilateral lentiginosis.
Romiti R, Harnache JDI, Neto CF, Kreuter A, Altmeyer P, Jansen T.
Department of Dermatology, University of Sao Paulo, Brazil.
J Dermatol 2001 Sep;28(9):490-2 Abstract quote
Partial unilateral lentiginosis is a rare pigmentary disorder characterized by multiple lentigines on otherwise normal skin affecting one side of the body. The histology is that of a lentigo.
We report two young men with an extensive form of partial unilateral lentiginosis affecting the skin. No systemic abnormalities could be identified.
HISTOLOGICAL TYPES CHARACTERIZATION GENERAL Increase in melanocytes and pigment within elongated rete ridges VARIANTS
CHARACTERIZATION SPECIAL STAINS Fontana Masson positive IMMUNOPEROXIDASE Melanocytes are S100 positive
DIFFERENTIAL DIAGNOSIS KEY DIFFERENTIATING FEATURES DYSPLASTIC NEVUS MELANOMA
PROGNOSIS AND TREATMENT CHARACTERIZATION PROGNOSTIC FACTORS Benign TREATMENT Simple excision
Weedon D. Weedon's Skin Pathology. Churchill Livingstone. 1997.
Fitzpatrick's Dermatology in General Medicine. 5th Edition. McGraw-Hill. 1999.
Robbins Pathologic Basis of Disease. Sixth Edition. WB Saunders 1999.
Last Updated 6/17/2002
mail to email@example.com with
questions or comments about this web site.
Copyright © 2002 The Doctor's Doctor